Schadendorf,
Ugurel,
Schuler-Thurner,
Nestle,
Enk,
Bröcker,
Grabbe,
Rittgen,
Edler,
Sucker,
Zimpfer-Rechner,
Berger,
Kamarashev,
Burg,
Jonuleit,
Tüttenberg,
Becker,
Keikavoussi,
Kämpgen,
Schuler,
- Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F.O., Enk, A., Bröcker, E.B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., Zimpfer-Rechner, C., Berger, T., Kamarashev, J., Burg, G., Jonuleit, H., Tüttenberg, A., Becker, J.C., Keikavoussi, P., Kämpgen, E., Schuler, G. Ann. Oncol. (2006)